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After publication of the original article \[[@CR1]\], the authors identified errors in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. The correct tables are given below.Table 1Baseline characteristic of participants according to different BP patterns diagnosed by criterion ATotal (N = 1714)NT (N = 672)WCH (N = 81)MH (N +  (N = 529)SH (N = 432)*P*Age (years)48.9 ± 13.846.7 ± 14.453.1 ± 14.4^a^49.9 ± 12.8^ab^50.0 ± 13.3^ab^\< 0.001Male, n (%)974 (56.8%)321 (47.8%)38 (46.9%)318 (60.1%)^ab^297 (68.8%)^abc^\< 0.001BMI (kg/m^2^)24.6 ± 3.923.9 ± 3.625.0 ± 4.0^a^24.8 ± 3.8^a^25.6 ± 4.1^ac^\< 0.001Smokers, n (%)623 (36.8%)188 (28.2%)24 (30.8%)213 (40.7%)^a^198 (46.7%)^abc^\< 0.001DM, n (%)366 (24.7%)94 (16.5%)18 (26.1%)^a^123 (26.9%)^a^131 (34.2%)^abc^\< 0.001CVD history, n (%)155 (9.0%)41 (6.1%)12 (14.8%)55 (10.4%)47 (10.9%)0.004Anti-hypertension, n (%) treatment1245 (76.7%)380 (61.8%)66 (85.7%)^a^422 (81.8%)^a^377 (90.8%)^ac^\< 0.001Causes of CKD\*\< 0.001 DKD212 (12.4%)35 (5.2%)11 (13.6%)^a^73 (13.8%)^a^93 (21.5%)^abc^ GN1048 (61.1%)489 (72.8%)40 (49.4%)^a^313 (59.2%)^a^206 (47.7%)^ac^ Others442 (25.8%)144 (21.4%)29 (35.8%)^a^140 (26.5%)129 (29.9%)^a^ ALB (g/L)38.3 ± 7.438.7 ± 7.239.4 ± 5.238.2 ± 7.637.7 ± 7.9^a^0.1 FBG (mmol/L)4.9 (4.4, 5.6)4.8 (4.3, 5.4)5.0 (4.5, 5.5)4.9 (4.4, 5.7)^a^5.0 (4.5, 5.9)^a^0.004 HGB (g/L)126.5 ± 22.4127.7 ± 19.55121.9 ± 22.2^a^126.3 ± 24.2125.7 ± 24.50.1 TG (mmol/L)1.8 (1.2, 2.5)1.7 (1.2, 2.4)1.8 (1.3, 2.4)1.9 (1.3, 2.6)^a^1.9 (1.3, 2.6)^a^0.004 TC (mmol/L)4.7 (3.9, 5.7)4.7 (3.9, 5.7)4.6 (3.8, 5.5)4.7 (3.9, 5.6)4.7 (3.9, 5.7)0.8 HDLC (mmol/L)1.1 (0.9, 1.3)1.1 (0.9, 1.4)1.0 (0.9, 1.3)1.0 (0.9, 1.3)^a^1.1 (0.9, 1.2)^a^0.001 LDLC (mmol/L)2.6 (2.1, 3.2)2.6 (2.1, 3.2)2.6 (2.1, 3.2)2.5 (2.1, 3.2)2.7 (2.2, 3.3)0.5 Cr (μmol/L)98 (141, 198)116.0 (80.0, 164.2)153.0 (106.7, 218.4)^a^151.0 (108.0, 204.5)^a^167.0 (122.0, 243.2)^ac^\< 0.001 eGFR (mL/min/1.73 m^2^)52.2 ± 30.162.9 ± 32.743.3 ± 24.3^a^48.2 ± 28.2^a^42.2 ± 23.3^ac^\< 0.001 24 h-Upro (g/L)1.0 (0.4, 2.4)0.7 (0.3, 1.5)1.0 (0.4, 2.9)^a^1.1 (0.4, 2.5)^a^1.8 (0.8, 3.5)^abc^\< 0.001CKD stages, n (%)\< 0.001 1256 (14.9%)174 (25.9%)5 (6.2%)^a^55 (10.4%)^a^22 (5.1%)^ac^ 2305 (17.8%)144 (21.4%)11 (13.6%)90 (17.0%)60 (13.9%)^a^ 3676 (39.5%)228 (33.9%)36 (44.4%)220 (41.6%)^a^192 (44.5%)^a^ 4477 (27.8%)126 (18.8%)29 (35.8%)^a^164 (31.0%)^a^158 (36.6%)^a^\* The diagnosis was made mainly basing on medical history and clinical features, with only 578 patients having renal biopsy confirmation. Among them, 513 patients were diagnosed as GN. IgAN constituted the majority of GN group (54.2%), following by mesangial proliferative glomerulonephritis (32.2%) and membranous nephropathy (10.5%). Others group included hypertensive nephropathy, tubulointerstitial nephritis, and cause unknown etc^a^*P *\< 0.05 comparison with NT^b^*P *\< 0.05 comparison with WCH^c^*P *\< 0.05 comparison with MHTable 2Clinical and ambulatory BP parameters of patientsTotalNTWCHMHSH*P*Criterion A Clinic SBP (mmHg)129.5 ± 17.3118.6 ± 11.1143.1 ± 13.4^a^124.9 ± 9.4^ab^149.4 ± 14.6^abc^\< 0.001 Clinic DBP(mmHg)80.6 ± 10.474.8 ± 7.487.9 ± 9.1^a^78.6 ± 6.5^ab^90.8 ± 10.5^abc^\< 0.001 24 h-SBP (mmHg)128.3 ± 17.0114.5 ± 8.3118.3 ± 7.3^a^134.8 ± 13.0^ab^143.6 ± 15.0^abc^\< 0.001 24 h-DBP (mmHg)79.3 ± 10.870.9 ± 6.070.6 ± 5.984.5 ± 8.2^ab^87.4 ± 10.0^abc^\< 0.001 D-SBP (mmHg)131.1 ± 17.0116.7 ± 8.9120.4 ± 7.5^a^136.4 ± 13.1^ab^145.1 ± 15.3^abc^\< 0.001 D-DBP (mmHg)80.7 ± 11.072.6 ± 6.372.3 ± 6.385.8 ± 8.5^ab^88.6 ± 10.5^abc^\< 0.001 N-SBP (mmHg)123.6 ± 18.7109.6 ± 10.0113.9 ± 10.5^a^130.4 ± 15.1^ab^138.9 ± 17.7^abc^\< 0.001 N-DBP (mmHg)75.4 ± 12.566.7 ± 7.566.6 ± 9.380.6 ± 11.1^ab^84.1 ± 11.1^abc^\< 0.001Criterion B Clinic SBP (mmHg)129.5 ± 17.3113.4 ± 9.7131.6 ± 12.0^a^117.4 ± 8.9^ab^139.1 ± 15.9^abc^\< 0.001 Clinic DBP (mmHg)80.6 ± 10.470.7 ± 6.283.4 ± 7.0^a^73.0 ± 5.5^ab^86.2 ± 9.5^abc^\< 0.001 24 h-SBP (mmHg)128.3 ± 17.0112.0 ± 8.3116.7 ± 8.0^a^131.5 ± 12.3^ab^138.6 ± 15.2^abc^\< 0.001 24 h-DBP (mmHg)79.3 ± 10.869.0 ± 5.971.7 ± 5.8^a^81.7 ± 8.1^ab^85.7 ± 9.5^abc^\< 0.001 D-SBP (mmHg)131.1 ± 17.0113.8 ± 8.3117.7 ± 7.3^a^133.8 ± 12.2^ab^140.4 ± 15.1^abc^\< 0.001 D-DBP (mmHg)80.7 ± 11.070.5 ± 5. 972.6 ± 5.4^a^83.7 ± 8.0^ab^87.1 ± 9.6^abc^\< 0.001 N-SBP (mmHg)123.6 ± 18.7107.5 ± 10.8113.5 ± 10.8^a^125.4 ± 14.4^ab^133.6 ± 17.8^abc^\< 0.001 N-DBP (mmHg)75.4 ± 12.564.9 ± 7.569.0 ± 7.9^a^76.9 ± 9.7^ab^81.9 ± 10.7^abc^\< 0.001*24* *h-SBP* 24-hour average ambulatory systolic blood pressure, *24* *h-DBP* 24-hour average ambulatory diastolic blood pressure, *D-SBP* daytime systolic blood pressure, *D-DBP* daytime diastolic blood pressure, *N-SBP* nighttime systolic blood pressure, *N-DBP* nighttime diastolic blood pressure
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